TP53 and non-Hodgkin lymphoma: A significantly increased risk of developing NHL was associated with the TP53 Arg/Pro genotype (OR = 1.73, 95% CI = 1.16–2.57, P = 0.007) or the Pro/Pro genotype (OR = 2.18, 95% CI = 1.32–3.59, P = 0.002) compared with the TP53 Arg/Arg genotype.